Published in Cell Stress Chaperones on July 04, 2009
Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update. Arch Toxicol (2012) 2.04
Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Front Immunol (2014) 0.97
Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck. Radiat Oncol (2014) 0.89
High levels of acute phase proteins and soluble 70 kDa heat shock proteins are independent and additive risk factors for mortality in colorectal cancer. Cell Stress Chaperones (2010) 0.83
Heat shock proteins as danger signals for cancer detection. Front Oncol (2011) 0.83
Pathology-dependent effects linked to small heat shock proteins expression: an update. Scientifica (Cairo) (2012) 0.79
Extracellular cell stress (heat shock) proteins-immune responses and disease: an overview. Philos Trans R Soc Lond B Biol Sci (2018) 0.76
Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90. Nat Commun (2017) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones (2005) 5.22
Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci (2006) 4.04
Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation (2002) 2.44
Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med (1999) 2.42
Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension (2003) 2.35
Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst (1995) 2.24
A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer (1995) 2.12
Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J Hypertens (2002) 2.05
Expression of the molecular chaperone Hsp70 in detergent-resistant microdomains correlates with its membrane delivery and release. J Biol Chem (2003) 2.02
Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res (2000) 1.99
Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals. Immunol Invest (1998) 1.79
Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals. Cell Stress Chaperones (1999) 1.62
Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res (2007) 1.61
An immunohistochemical analysis of heat shock protein 70, p53, and estrogen receptor status in carcinoma of the uterine cervix. Gynecol Oncol (1999) 1.59
Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J Pathol (2005) 1.53
Serum levels of Hsp 72 measured early after trauma correlate with survival. J Trauma (2002) 1.49
Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart (2005) 1.38
Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler Thromb Vasc Biol (2003) 1.36
Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity. Eur J Immunol (2005) 1.34
Heat shock proteins and cell proliferation in human breast cancer biopsy samples. Cancer Detect Prev (1997) 1.28
Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Ann Surg Oncol (2008) 1.23
Elevated levels of circulating heat shock protein 70 (Hsp70) in peripheral and renal vascular disease. Heart Vessels (2000) 1.23
Elevated circulating levels of heat shock protein 70 are related to systemic inflammatory reaction through monocyte Toll signal in patients with heart failure after acute myocardial infarction. Eur J Heart Fail (2006) 1.19
Plasma levels of heat shock protein 70 in patients with prostate cancer: a potential biomarker for prostate cancer. Clin Prostate Cancer (2004) 1.14
Proliferating cell nuclear antigen and heat shock protein 70 immunolocalization in invasive ductal breast cancer not otherwise specified. Breast Cancer Res Treat (1997) 1.14
Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries. APMIS (2003) 1.13
Gender differences in the expression of heat shock proteins: the effect of estrogen. Am J Physiol Heart Circ Physiol (2003) 1.10
Current TNM staging of colorectal cancer. Lancet Oncol (2007) 1.08
Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case-control study. J Hum Hypertens (2006) 1.07
Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer. Eur Surg Res (2007) 1.07
Elevated serum heat-shock protein 70 levels in patients with acute infection: use of an optimized enzyme-linked immunosorbent assay. Scand J Immunol (2003) 1.06
Membrane-bound heat shock protein 70 (Hsp70) in acute myeloid leukemia: a tumor specific recognition structure for the cytolytic activity of autologous NK cells. Haematologica (2003) 1.02
Patient survival by Hsp70 membrane phenotype: association with different routes of metastasis. Cancer (2007) 1.02
Heat shock protein 70 membrane expression and melanoma-associated marker phenotype in primary and metastatic melanoma. Melanoma Res (2003) 1.01
Serum heat shock protein 70 level as a biomarker of exceptional longevity. Mech Ageing Dev (2006) 1.01
Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer. J Gastroenterol Hepatol (2003) 0.98
CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer. Hepatogastroenterology (2002) 0.98
Differential expression of 70-kDa heat shock-protein in human oral tumorigenesis. Int J Cancer (1995) 0.97
Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer. J Surg Oncol (2009) 0.94
Origin of immunomodulation after soft tissue trauma: potential involvement of extracellular heat-shock proteins. Shock (2007) 0.93
Serum heat shock protein 70 levels are decreased in normal human pregnancy. J Reprod Immunol (2007) 0.92
Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients. Cancer Detect Prev (2003) 0.92
Serum heat shock protein 70 levels and lung cancer risk: a case-control study nested in a large cohort study. Cancer Epidemiol Biomarkers Prev (2006) 0.91
Sexual dimorphism of the intracellular heat shock protein 72 response. J Appl Physiol (1985) (2006) 0.90
Elevated serum 70 kDa heat shock protein level reflects tissue damage and disease severity in the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Eur J Obstet Gynecol Reprod Biol (2008) 0.90
Correlation of heat shock protein 70 expression with estrogen receptor levels in invasive human breast cancer. Am J Clin Pathol (1994) 0.89
Adoptive transfer of human natural killer cells in mice with severe combined immunodeficiency inhibits growth of Hsp70-expressing tumors. Int J Cancer (2000) 0.88
Preoperative treatment of rectal cancer with radiation, chemotherapy and hyperthermia: analysis of treatment efficacy and heat-shock response. Radiat Res (1999) 0.87
Circulating anti-heat-shock-protein antibodies in normal pregnancy and preeclampsia. Cell Stress Chaperones (2009) 0.87
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol (2004) 3.07
Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression. Diabetes Care (2003) 2.64
Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J (2009) 2.37
Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. J Allergy Clin Immunol (2007) 1.78
Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol (2008) 1.76
Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events. Circulation (2002) 1.65
Activation of the complement system in normal pregnancy and preeclampsia. Mol Immunol (2010) 1.37
The R1141X loss-of-function mutation of the ABCC6 gene is a strong genetic risk factor for coronary artery disease. Genet Test Mol Biomarkers (2010) 1.31
Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index. J Immunol (2003) 1.24
Immunological aspects of heat-shock proteins-the optimum stress of life. Mol Immunol (2004) 1.23
Heat shock protein 70 is a potent activator of the human complement system. Cell Stress Chaperones (2002) 1.20
Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL-1β, TNF-α, and LPS. Cytometry A (2010) 1.18
Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia. Reprod Biol Endocrinol (2011) 1.18
Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function. J Immunol (2009) 1.13
Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia. Cell Stress Chaperones (2008) 1.13
Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis (2004) 1.09
Human fetuin/alpha2HS-glycoprotein level as a novel indicator of liver cell function and short-term mortality in patients with liver cirrhosis and liver cancer. Eur J Gastroenterol Hepatol (2002) 1.08
Modified low density lipoproteins differentially bind and activate the C1 complex of complement. Mol Immunol (2006) 1.08
4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study. Crit Care (2010) 1.05
Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation (2002) 1.03
Circulating heat shock protein 70 (HSPA1A) in normal and pathological pregnancies. Cell Stress Chaperones (2009) 1.02
Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics (2003) 1.01
Studies on the interactions between C-reactive protein and complement proteins. Immunology (2007) 1.01
Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. J Allergy Clin Immunol (2005) 0.98
Interaction of serum 70-kDa heat shock protein levels and HspA1B (+1267) gene polymorphism with disease severity in patients with chronic heart failure. Cell Stress Chaperones (2008) 0.96
Paradoxical alteration of acute-phase protein levels in patients with chronic hepatitis C treated with IFN-alpha2b. Int Immunol (2004) 0.95
Increased circulating heat shock protein 70 levels in pregnant asthmatics. Cell Stress Chaperones (2009) 0.95
Serum level of soluble Hsp70 is associated with vascular calcification. Cell Stress Chaperones (2010) 0.95
Complement activation in animal and human pregnancies as a model for immunological recognition. Mol Immunol (2011) 0.94
Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedema. Helicobacter (2007) 0.94
Red cell distribution width: a powerful prognostic marker in heart failure. Eur J Heart Fail (2010) 0.93
Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. Atherosclerosis (2004) 0.93
High rate of early restenosis after carotid eversion endarterectomy in homozygous carriers of the normal mannose-binding lectin genotype. Stroke (2005) 0.92
Serum heat shock protein 70 levels are decreased in normal human pregnancy. J Reprod Immunol (2007) 0.92
Polymorphisms of TNF-alpha and LT-alpha genes in multiple myeloma. Leuk Res (2008) 0.91
Lipid, haemostatic and inflammatory variables in relation to the estrogen receptor alpha (ESR1) PvuII and XbaI gene polymorphisms. Clin Chim Acta (2007) 0.90
The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis. Int Immunol (2006) 0.90
Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer. Int J Cancer (2013) 0.90
The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk. Int J Cancer (2007) 0.90
Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction. Clin Chim Acta (2008) 0.90
Elevated serum 70 kDa heat shock protein level reflects tissue damage and disease severity in the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Eur J Obstet Gynecol Reprod Biol (2008) 0.90
Clinical management of hereditary angio-oedema in children. Pediatr Allergy Immunol (2002) 0.90
Comparative analysis of linear antibody epitopes on human and mycobacterial 60-kDa heat shock proteins using samples of healthy blood donors. Int Immunol (2003) 0.89
Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes. Atherosclerosis (2008) 0.89
The effect of long-term danazol prophylaxis on liver function in hereditary angioedema-a longitudinal study. Eur J Clin Pharmacol (2009) 0.89
Antibodies against the human heat shock protein hsp70 in patients with severe coronary artery disease. Immunol Invest (2002) 0.89
Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores. BMC Gastroenterol (2007) 0.88
Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor h and factor h-related protein 1 to pentraxin 3. J Immunol (2012) 0.88
Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia. Thromb Haemost (2009) 0.88
Low ficolin-3 levels in early follow-up serum samples are associated with the severity and unfavorable outcome of acute ischemic stroke. J Neuroinflammation (2011) 0.88
MBL and C1q compete for interaction with human endothelial cells. Mol Immunol (2006) 0.88
Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia. Clin Chim Acta (2011) 0.87
Circulating anti-heat-shock-protein antibodies in normal pregnancy and preeclampsia. Cell Stress Chaperones (2009) 0.87
Estrogen receptor alpha (ESR1) PvuII and XbaI gene polymorphisms in ischemic stroke in a Hungarian population. Clin Chim Acta (2007) 0.87
Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia. BMC Med Genet (2009) 0.87
Functional analysis of the mannose-binding lectin complement pathway in normal pregnancy and preeclampsia. J Reprod Immunol (2010) 0.86
Differences in the genetic background of latent autoimmune diabetes in adults (LADA) and type 1 diabetes mellitus. Immunol Lett (2002) 0.86
Traitors of the immune system-enhancing antibodies in HIV infection: their possible implication in HIV vaccine development. Vaccine (2008) 0.86
Genetic basis of tobacco smoking: strong association of a specific major histocompatibility complex haplotype on chromosome 6 with smoking behavior. Int Immunol (2004) 0.86
Chaperone-related immune dysfunction: an emergent property of distorted chaperone networks. Trends Immunol (2005) 0.86
Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter (2002) 0.86
Novel anti-cholesterol monoclonal immunoglobulin G antibodies as probes and potential modulators of membrane raft-dependent immune functions. J Lipid Res (2006) 0.85
Anti-mutated citrullinated vimentin (anti-MCV) and anti-65 kDa heat shock protein (anti-hsp65): new biomarkers in ankylosing spondylitis. Joint Bone Spine (2011) 0.85
Relationship between complement components C4A and C4B diversities and two TNFA promoter polymorphisms in two healthy Caucasian populations. Hum Immunol (2003) 0.85
Complement anaphylatoxin C3a as a novel independent prognostic marker in heart failure. Clin Res Cardiol (2012) 0.85
Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report. Medicine (Baltimore) (2014) 0.85
Serum fetuin-A in metabolic and inflammatory pathways in patients with myocardial infarction. Eur J Clin Invest (2011) 0.84
Interleukin-6 -174 promoter polymorphism does not influence IL-6 production after LPS and IL-1 beta stimulation in human umbilical cord vein endothelial cells. Cytokine (2007) 0.84
Elevated complement C3 is associated with early restenosis after eversion carotid endarterectomy. Thromb Haemost (2006) 0.84
Preeclampsia is associated with decreased serum alpha(2)-HS glycoprotein (fetuin-A) concentration. Hypertens Res (2009) 0.84
Proinflammatory changes in human umbilical cord vein endothelial cells can be induced neither by native nor by modified CRP. Int Immunol (2006) 0.84